TRADING UPDATES: Capital meets top end of view; Yu Group revenue rises
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
| Price | 73.00p on 10-02-2026 at 18:35:08 |
|---|---|
| Change | -4.50p -5.81% |
| Buy | 76.00p |
| Sell | 70.00p |
| Last Trade: | Buy 6,583.00 at 75.87p |
| Day's Volume: | 200,063 |
| Last Close: | 73.00p |
| Open: | 77.50p |
| ISIN: | GB00B0BRN552 |
| Day's Range | 73.00p - 76.00p |
| 52wk Range: | 64.00p - 128.00p |
| Market Capitalisation: | £56.20m |
| VWAP: | 75.29803p |
| Shares in Issue: | 76.99m |
Sector: Software and Computing
Listed In: FTSE AIM All-Share,
Bango (BGO) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 6,583 | 75.87p | Ordinary |
16:22:20 - 10-Feb-26 |
| Buy* | 6,598 | 75.70p | Ordinary |
16:20:30 - 10-Feb-26 |
| Buy* | 13,243 | 75.44p | Ordinary |
16:18:25 - 10-Feb-26 |
| Buy* | 1,500 | 73.275p | Ordinary |
16:17:13 - 10-Feb-26 |
| Buy* | 385 | 75.45p | Ordinary |
16:06:22 - 10-Feb-26 |
| Buy* | 1,000 | 75.45p | Ordinary |
15:56:59 - 10-Feb-26 |
| Buy* | 1,257 | 73.0666p | Ordinary |
15:33:51 - 10-Feb-26 |
| Unknown* | 10,000 | 73.00p | Ordinary |
15:32:40 - 10-Feb-26 |
| Buy* | 6,621 | 75.45p | Ordinary |
15:02:43 - 10-Feb-26 |
| Buy* | 6,661 | 75.00p | Ordinary |
15:01:11 - 10-Feb-26 |
Bango (BGO) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 6th Feb 2026 2:04 pm | RNS | Director/PDMR Shareholding |
| 2nd Feb 2026 7:00 am | RNS | Total Voting Rights |
| 30th Jan 2026 7:00 am | RNS | Director/PDMR Shareholding |
| 28th Jan 2026 9:42 am | RNS | Director/PDMR Shareholding |
| 28th Jan 2026 7:00 am | RNS | Director/PDMR Shareholding |
| 28th Jan 2026 7:00 am | RNS-R | KDDI selects the DVM from Bango |
| 20th Jan 2026 7:00 am | RNS | Trading Update |
| 3rd Nov 2025 10:01 am | RNS | Total Voting Rights |
| 1st Oct 2025 1:47 pm | RNS | Total Voting Rights |
| 17th Sep 2025 9:11 am | RNS | Director/PDMR Shareholding |